Beam Therapeutics
Stock Forecast, Prediction & Price Target
Beam Therapeutics Financial Estimates
Beam Therapeutics Revenue Estimates
Beam Therapeutics EBITDA Estimates
Beam Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $51.84M N/A | $60.92M 17.50% | $377.70M 520.00% | Avg: $52.03M Low: $17.63M High: $70.55M avg. -86.22% | Avg: $59.40M Low: $17.87M High: $86.15M avg. 14.15% | Avg: $81.89M Low: $24.64M High: $118.76M avg. 37.85% | Avg: $216.85M Low: $65.25M High: $314.50M avg. 164.81% |
Net Income
% change YoY
| $-341.36M N/A | $-263.58M 22.78% | $-132.52M 49.72% | Avg: $-432.10M Low: $-435.90M High: $-254.60M avg. -226.05% | Avg: $-454.43M Low: $-481.42M High: $-212.93M avg. -5.16% | Avg: $-362.56M Low: $-574.79M High: $-33.06M avg. 20.21% | Avg: $-261.45M Low: $-414.51M High: $-23.84M avg. 27.88% |
EBITDA
% change YoY
| $-414.30M N/A | $-401.48M 3.09% | $-156.47M 61.02% | Avg: $-45.94M Low: $-62.29M High: $-15.57M avg. 70.63% | Avg: $-52.44M Low: $-76.06M High: $-15.78M avg. -14.15% | Avg: $-72.29M Low: $-104.85M High: $-21.75M avg. -37.85% | Avg: $-191.45M Low: $-277.66M High: $-57.61M avg. -164.81% |
EPS
% change YoY
| -$5.31 N/A | -$3.76 29.19% | -$1.72 54.25% | Avg: -$4.72 Low: -$5.65 High: -$3.3 avg. -174.55% | Avg: -$4.71 Low: -$6.24 High: -$2.76 avg. 0.21% | Avg: -$4.7 Low: -$7.45 High: -$0.43 avg. 0.27% | Avg: -$3.39 Low: -$5.37 High: -$0.31 avg. 27.88% |
Operating Expenses
% change YoY
| $444.30M N/A | $399.39M -10.10% | $554.19M 38.75% | Avg: $24.75B Low: $8.39B High: $33.56B avg. 4366.06% | Avg: $28.25B Low: $8.50B High: $40.97B avg. 14.15% | Avg: $38.95B Low: $11.72B High: $56.49B avg. 37.85% | Avg: $103.14B Low: $31.03B High: $149.59B avg. 164.81% |
FAQ
What is Beam Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -45.77% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is -435.90M, average is -432.10M and high is -254.60M.
What is Beam Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 32.64% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $17.63M, average is $52.03M and high is $70.55M.
What is Beam Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -36.54% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is -$5.65, average is -$4.72 and high is $-3.3.
What is the best performing analyst?
In the last twelve months analysts have been covering Beam Therapeutics stock. The most successful analyst is Rick Bienkowski.